Therapeutic efficacies of isoniazid and rifampin encapsulated in lung-specific stealth liposomes against Mycobacterium tuberculosis infection induced in mice

Deol, P, Khuller, G K, Joshi, K·1997·Antimicrobial Agents and Chemotherapy
DOI 10.1128/aac.41.6.1211

Cited by (128)

Items 101–128 of 128

  1. Nanomedicines in Tuberculosis: Diagnosis, Therapy and Nanodrug Delivery
    Abdel Naser Dakkah, Yazan A. Bataineh, Bilal A. Al-Jaidi, Mohammad F. Bayan, Nabil Awni Nimer · 2020 · Engineering materials
  2. Anti-infectives
    Abeer H. A. Mohamed-Ahmed, Claire Ginn, Simon L. Croft, Stephen Brocchini · 2013 · Springer eBooks
  3. Isoniazid Encapsulated Liposomes Drug Delivery as an Anti-Tubercular Agents: from Pre-clinical to Clinical Investigations
    Ridahunlang Nongkhlaw, Yogesh Mahadu Khetmalis, Ridaphun Nongrum, Jaganath Arunachalam, Rishanlang Nongkhlaw · 2025 · Journal of Pharmaceutical Innovation
  4. Determination of rifampicin location in cholesterol-lipid liposomes by 2H and 31P Solid-State NMR
    Narumon Changsan, Frances Separovic, Teerapol Srichana · 2008 · IEEE International Nanoelectronics Conference
  5. Nanopharmaceuticals in immunology
    Ranjita Shegokar, Ana Rita Fernandes, Eliana B. Souto · 2018 · Elsevier eBooks
  6. Challenges and Advances in TB Drug Discovery
    Garima Khare, Prachi Nangpal, Anil K. Tyagi · 2019 · Springer eBooks
  7. Advances in nanomaterials-assisted drug delivery, diagnosis, and action towards drug-resistant Mycobacterium
    Parikshana Mathur, Pinky Choudhary, Rajkuberan Chandrasekaran, Ragini Singh, Hemant Kumar Daima · 2025 · Progress in Biophysics and Molecular Biology
  8. Nanotechnology-based novel approaches for the treatment of tuberculosis
    N. Afreen, M. Shamshath Begum, Smriti Sharma · 2026 · Next Nanotechnology
  9. Nanoparticle carriers in the treatment of intracellular bacterial infections: Current approaches and challenges
    Zheng Lu, Bin He, Zhixin Lei, Lijun Wu, Dongyang Ye, Dan Xu, Shanqi Cheng, Xiaotian Zhang, Ziqi Weng · 2026 · International Journal of Pharmaceutics X
  10. LIPOSOME AS A DRUG DELIVERY CARRIER-A REVIEW
    Rekha Kumari, K. DILEEP VARMA, Surabhi Srivastava, Jyoti Rai Prachya, Sheo Datta Maurya · 2013 · International Journal of Drug Regulatory Affairs
  11. Factors Influencing the Properties of Rifampicin Liposome and Applications for Dry Powder Inhaler
    Narumon Changsan, Teerapol Srichana · 2007 · IEEE International Conference on Nano/Micro Engineered and Molecular Systems
  12. Estudio de la penetración de agente antiinfecciosos en macrófagos utilizando eritrocitos portadores
    Elsa Briones Cuesta · 2009
  13. FORMULATION AND EVALUATION OF RIFAMPICIN SOLID LIPID NANOPARTICLES
    Mangukia Dhruv · 2013 · Journal of Drug Discovery and Therapeutics
  14. Intracellular Bacteria and Protozoa
    María José Morilla, Eder Lilia Romero · 2011 · Fundamental biomedical technologies
  15. FACULDADE DE CIÊNCIAS FARMACÊUTICAS Programa de Pós-Graduação em Farmácia Área de Análises Clínicas Novas formulações de fármacos tuberculostáticos em dispersões de brometo de dioctadecildimetilamônio: preparação, caracterização e avaliação da atividade in vitro contra micobactérias
    Lílian Barbassa · 2010
  16. Development of liposome formulations of ethambutol, rifampicin, and isoniazid for pulmonary treatment of tuberculosis
    Theresa Wiens · 2009 · cIRcle (University of British Columbia)
  17. Regimens of the Chemotherapy for Urogenital Tuberculosis
    Ekaterina Kulchavenya · 2016 · Springer eBooks
  18. Evaluation of liposomal bismuth-ethanedithiol-tobramycin for treatment of cystic fibrosis pulmonary pseudomonas aeruginosa infection
    Moayad Alhariri · 2013 · Lu Zone Ul (Laurentian University)
  19. Clinical perspectives of nanotherapy in tuberculosis treatment
    Kapil Sharma · 2021 · Elsevier eBooks
  20. Preparation of pyrazinamide and levofloxacin proliposomes and feasibility in tuberculosis treatments
    Wipaporn Rojanarat · 2012 · PSU Knowledge Bank (Prince of Songkla University)
  21. Literature Alerts
    1998 · Journal of Microencapsulation
  22. Encapsulação de isoniazida, pirazinamida e estreptomicina em lipossomas para a administração por inalação
    Chrissana Santos Calheiros · 2001
  23. Arthritis
    2008 · Elsevier eBooks
  24. Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment
    Davide M. Ferraris, Riccardo Miggiano, Menico Rizzi · 2020 · MDPI eBooks
  25. Liposomal Antibiotics for the Treatment of Infectious Diseases
    Mr. Sadanand G Bondre, Mr. Suraj B. Rathod, Nitin B. Kohle, Mr. Naved Khan · 2023 · International Journal of Advanced Research in Science Communication and Technology
  26. Urgency of novel anti-tuberculosis strategies: a prospective challenge
    Kausar A. Malik, Aleem Razzaq, Hafiz Ghufran, Muhammad Abid Naseer, Yahya Tariq, Zaheer Abbas, Muhammad Hamza Basit, Arshia Nazir, Adeena Saeed, Rashid Bhatti et al. · 2019 · International Journal of Biosciences (IJB)
  27. Particulate systems for lung delivery of pyrazinamide for tuberculosis treatment
    Dinh Duy Pham · 2014 · theses.fr (ABES)
  28. Formulation et évaluation de nanovecteurs polymères porteurs d'anticorps pour une délivrance ciblée d'antibiotiques.
    Hung Lê · 2019 · theses.fr (ABES)